George C. Garrow

443 total citations
9 papers, 333 citations indexed

About

George C. Garrow is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, George C. Garrow has authored 9 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in George C. Garrow's work include Lung Cancer Research Studies (3 papers), Cancer therapeutics and mechanisms (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). George C. Garrow is often cited by papers focused on Lung Cancer Research Studies (3 papers), Cancer therapeutics and mechanisms (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). George C. Garrow collaborates with scholars based in United States and Germany. George C. Garrow's co-authors include Kenneth R. Hande, A. Y. Chang, Robert F. Asbury, László G. Boros, John D. Hainsworth, Dina Johnson, Sanjeev Kaul, F. Anthony Greco, Rashmi H. Barbhaiya and Dana S. Thompson and has published in prestigious journals such as The American Journal of Medicine, Clinical Pharmacology & Therapeutics and Lung Cancer.

In The Last Decade

George C. Garrow

9 papers receiving 321 citations

Peers

George C. Garrow

PRM

PPCH

ONCOL

MB

SURGE

G. Krajnik Austria

A. Iop Italy

J. McClean United States

Joshua A. Halpern United States

J. Vinke United Kingdom

Nedal Bukhari Saudi Arabia

Henry J. Legere United States

Andrea Wahner Hendrickson United States

Matthew Boron United States

I. Karyotis Greece

G. Krajnik Austria

George C. Garrow

136 ×0.7

PRM

41 ×0.3

PPCH

250 ×1.7

ONCOL

58 ×0.5

MB

26 ×0.7

SURGE

Citations per year, relative to George C. Garrow George C. Garrow (= 1×) peers G. Krajnik

Countries citing papers authored by George C. Garrow

Since Specialization

Citations

This map shows the geographic impact of George C. Garrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George C. Garrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George C. Garrow more than expected).

Fields of papers citing papers by George C. Garrow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George C. Garrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George C. Garrow. The network helps show where George C. Garrow may publish in the future.

Co-authorship network of co-authors of George C. Garrow

This figure shows the co-authorship network connecting the top 25 collaborators of George C. Garrow. A scholar is included among the top collaborators of George C. Garrow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George C. Garrow. George C. Garrow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Chang, Alice Y., et al.. (1999). Ifosfamide, carboplatin and etoposide (ICE) in metastatic and refractory breast cancer. Cancer Chemotherapy and Pharmacology. 44(0). S26–S28. 9 indexed citations

2.

Chang, A. Y., et al.. (1996). Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.. PubMed. 23(3 Suppl 6). 74–7. 7 indexed citations

3.

Thompson, Dana S., F. Anthony Greco, Antonius A. Miller, et al.. (1995). A phase I study of etoposide phosphate administered as a daily 30-minute infusion for 5 days*. Clinical Pharmacology & Therapeutics. 57(5). 499–507. 20 indexed citations

4.

Chang, A. Y., et al.. (1995). Ifosfamide/carboplatin/etoposide chemotherapy in patients with metastatic non-small cell lung cancer. Lung Cancer. 13(3). 345–345. 4 indexed citations

5.

Chang, A. Y. & George C. Garrow. (1995). Pilot study of vinorelbine (Navelbine) and paclitaxel (Taxol) in patients with refractory breast cancer and lung cancer.. PubMed. 22(2 Suppl 5). 66–70; discussion 70. 33 indexed citations

6.

Chang, A. Y., László G. Boros, George C. Garrow, & Robert F. Asbury. (1995). Paclitaxel by 3-hour infusion followed by 96-hour infusion on failure in patients with refractory malignant disease.. PubMed. 22(3 Suppl 6). 124–7. 24 indexed citations

7.

Hande, Kenneth R. & George C. Garrow. (1993). Acute tumor lysis syndrome in patients with high-grade non-Hodgkin's lymphoma. The American Journal of Medicine. 94(2). 133–139. 216 indexed citations

8.

Garrow, George C., John D. Hainsworth, & Dina Johnson. (1992). PROLONGED ADMINISTRATION OF ORAL ETOPOSIDE IN PREVIOUSLY TREATED EPITHELIAL OVARIAN CANCER. A PHASE II TRIAL. 11. 236–236. 16 indexed citations

9.

Garrow, George C. & David H. Johnson. (1992). Treatment of "good risk" metastatic testicular cancer.. PubMed. 19(2). 159–65. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact